Portfolio Company · Operating Co.

Novus Biologicals

eCommerce and Life Sciences Company

backed byMainsail Partners

ExitedeCommerce and Life Sciences Company

Novus Biologicals

a portfolio company of

Mainsail Partners

Status on record: Exited

PE Firm Index

Who owns Novus Biologicals?

Novus Biologicals is listed as an exited portfolio company of Mainsail Partners on Mainsail Partners' own portfolio page.

Company Snapshot

Novus Biologicals is a eCommerce and Life Sciences Company company. Its owner on record, Mainsail Partners, is a growth equity firm. Mainsail Partners lists at least 59 companies in the index, 1 of them in eCommerce and Life Sciences Company.

SectoreCommerce and Life Sciences Company

Parent PE firmMainsail Partners

Ownership statusExited

WebsiteNot on record

About the owner

Mainsail Partners

Strategy: Growth equity, Investments in bootstrapped companies, Founder-led investments
Sectors: B2B software, AI-enabled companies, Vertical market leaders
Companies in the index: At least 59

Mainsail Partners is a growth equity firm that invests in founder-led, bootstrapped B2B software and AI-enabled companies.

Read the Mainsail Partners profile

Questions about Novus Biologicals

Who owns Novus Biologicals?

Novus Biologicals is listed as an exited portfolio company of Mainsail Partners on Mainsail Partners' own portfolio page.

What sector is Novus Biologicals in?

Novus Biologicals is in eCommerce and Life Sciences Company. Classified from the owner's portfolio label.

Sources

Mainsail Partners
https://mainsailpartners.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Novus Biologicals and does not provide investment advice.

Other portfolio companies of Mainsail Partners

6 of 58 shown

Cash Management Solutions

Provider of Revenue Management Services

See the full Mainsail Partners portfolio.

Other eCommerce and Life Sciences Company portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Mainsail Partners

Status: Exited

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.